DRUGSUCCESS.AI Trademark
DRUGSUCCESS.AI is a USPTO trademark filed by ThinkBio.Ai., Inc.. Status: Registered.
Trademark Facts
| Mark | DRUGSUCCESS.AI |
|---|---|
| Serial Number | 99438890 |
| Registration Number | 8236127 |
| Status | Registered |
| Filing Date | 2025-10-12 |
| Registration Date | 2026-04-28 |
| Mark Type | Word |
| Nice Classes | 042 (Software & IT) |
| Owner | ThinkBio.Ai., Inc. |
| Attorney of Record | MICHAEL LEE EVANS |
| Prosecution Events | 17 |
| Latest Event | NRCS on 2026-04-28 |
Goods & Services
Class 042: AI-driven platform that forecasts therapeutic success prior to clinical investment integrating disease models, target genetics, multi omics, preclinical evidence, and curated public data. Using advanced AI and statistical models, calculates a drug success core to predict therapeutic progression from preclinical to approval.
Recent Prosecution Activity
| Date | Document | Type |
|---|---|---|
| 2026-04-28 | Registration Certificate | ORC |
| 2026-04-28 | Notice of Registration Email | ERO |
| 2026-04-01 | TRAM Snapshot of App at Pub for Oppostn | PST |
| 2026-03-20 | Examiner's Amendment | EXAMA |
| 2026-03-20 | Public Note | PNR |
| 2026-03-20 | Amendment and Mail Process Complete | AMC |
USPTO Refusals on Record
- indefinite_identification
- merely_descriptive